Iterum Therapeutics plc (ITRMF) Interest Coverage Ratio (2017 - 2025)
Iterum Therapeutics (ITRMF) posted quarterly Interest Coverage Ratio of 0.66 for Q3 2025, up 89.83% year-over-year from 0.35 in Q3 2024, and down 43.97% quarter-over-quarter from 0.46 in Q2 2025.
Iterum Therapeutics plc (ITRMF) Interest Coverage Ratio (2017 - 2025) Analysis & Trends
Iterum Therapeutics' Interest Coverage Ratio history runs 9 years deep, the most recent figure standing at 0.66 for Q3 2025.
- In Q3 2025, Interest Coverage Ratio rose 89.83% year-over-year to 0.66; the TTM figure through Sep 2025 stood at 1.75 (up 85.05% YoY), while the FY2024 annual figure was 0.42, up 63.16% from the prior year.
- Interest Coverage Ratio for Q3 2025 stood at 0.66, down from 0.46 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 0.46 in Q2 2025, with the low at 124.16 in Q4 2021.
- The 5-year median for Interest Coverage Ratio is 2.44 (2023), against an average of 12.75.
- The sharpest annual moves came in 2021 and 2022: Interest Coverage Ratio slumped 26139.04% in 2021, then surged 97.71% in 2022.
- Iterum Therapeutics' Interest Coverage Ratio stood at 124.16 in 2021, then soared by 98.97% to 1.28 in 2022, then tumbled by 259.13% to 4.61 in 2023, then surged by 71.22% to 1.33 in 2024, then surged by 50.42% to 0.66 in 2025.
- Business Quant data shows ITRMF's Interest Coverage Ratio at 0.66 in Q3 2025, 0.46 in Q2 2025, and 5.41 in Q1 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.66 |
| Jun 30, 2025 | -0.46 |
| Mar 31, 2025 | -5.41 |
| Dec 31, 2024 | -1.33 |
| Sep 30, 2024 | -6.46 |
| Jun 30, 2024 | -5.30 |
| Mar 31, 2024 | -8.23 |
| Dec 31, 2023 | -4.61 |
| Sep 30, 2023 | -5.31 |
| Jun 30, 2023 | -2.90 |
| Mar 31, 2023 | -1.98 |
| Sep 30, 2022 | -1.28 |
| Jun 30, 2022 | -1.32 |
| Mar 31, 2022 | -1.11 |
| Dec 31, 2021 | -124.16 |
| Sep 30, 2021 | -0.62 |
| Jun 30, 2021 | -57.74 |
| Mar 31, 2021 | -0.63 |
| Dec 31, 2020 | -20.28 |
| Sep 30, 2020 | -0.17 |